skip to Main Content

Cancer Services

Gynaecological Cancer

Please see below all current gynaecological cancer clinical trials of the Central Coast Cancer Centre.

Name: ORCCYD

A Randomized, Open-Label Study Comparing the Combination of YONDELIS® and DOXIL®/CAELYX® With DOXIL®/CAELYX® Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer.

Protocol Number: ET743-OVC-3
Principal Investigator: Dr Susan Tiley
Study Coordinator: Leonie Kelly
Status: Recruiting
Condition: Gynaecological Cancer

More information about ORCCYD

Name: VELIA

A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel With or Without Concurrent and Continuation Maintenance Veliparib (PARP inhibitor) in Subjects with Previously Untreated Stages III or IV High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

Protocol Number: M13-694
Principal Investigator: Dr Susan Tiley
Study Coordinator: Leonie Kelly
Status: Recruiting
Condition: Gynaecological Cancer

More information about Ovarian Cancer Study

More information

For more information about medical oncology clinical trials please contact the Nurse Unit Manager on 02 4320 3940 or see:

Internal page Research and Clinical Trials

Back To Top